Analysis of Soluble Interleukin-2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD.

Klyscz P, Otto C, Ruprecht K, Asseyer S, Tiedt HO, Meisel C, Bellmann-Strobl J, Paul F, Schindler P

Open source

DOI
10.1002/acn3.70186
Published
2025 Dec
Container
Annals of clinical and translational neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.70186,
  title = {Analysis of Soluble Interleukin-2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD.},
  author = {Klyscz P and Otto C and Ruprecht K and Asseyer S and Tiedt HO and Meisel C and Bellmann-Strobl J and Paul F and Schindler P},
  year = {2025},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.70186},
  url = {https://doi.org/10.1002/acn3.70186}
}

RIS

TY  - JOUR
TI  - Analysis of Soluble Interleukin-2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD.
AU  - Klyscz P
AU  - Otto C
AU  - Ruprecht K
AU  - Asseyer S
AU  - Tiedt HO
AU  - Meisel C
AU  - Bellmann-Strobl J
AU  - Paul F
AU  - Schindler P
PY  - 2025
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.70186
UR  - https://doi.org/10.1002/acn3.70186
ER  - 

APA

P, K., C, O., K, R., S, A., HO, T., C, M., J, B., F, P., & P, S. (2025). Analysis of Soluble Interleukin-2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.70186

Source records